Gainsborough Investment Partners

Our Gainsborough partnership invests in companies quoted on AIM and Plus markets. The partnership will develop a portfolio of approximately 20 companies.  Gainsborough will allocate 20% of its funds to approximately 10 "Earlier Companies" and 80% of its assets to approximately 10 Later Companies.  This defensive asset allocation profile will give partners exposure to exciting younger companies, while giving the portfolio a base of more developed companies.

To date the partnership has invested in the following companies:

• Plastics Capital plc (http://www.plasticscapital.com/)
• Surface Transforms plc (http://www.surface-transforms.com/)
• Immunodiagnostic Systems Holdings plc (http://www.idsltd.com)
• BrainJuicer Group plc (www.brainjuicer.com)
• Scancell Holdings plc (www.scancell.co.uk)
• Omega Diagnostics Group plc (www.omegadiagnostics.com)